BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 5360244)

  • 1. Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma.
    Hausknecht RU; Gusberg SB
    Am J Obstet Gynecol; 1969 Dec; 105(8):1161-7. PubMed ID: 5360244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen metabolism in patients at high risk for endometrial carcinoma. II. The role of androstenedione as an estrogen precursor in postmenopausal women with endometrial carcinoma.
    Hausknecht RU; Gusberg SB
    Am J Obstet Gynecol; 1973 Aug; 116(7):981-4. PubMed ID: 4718225
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissimilar isotopic ratios in urinary estrogens following simultaneous injection of delta-4-androstenedione-14C and estrone-6,7-3H.
    Kelly WG; Rizkallah TH
    J Clin Endocrinol Metab; 1973 Jan; 36(1):196-9. PubMed ID: 4734136
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer.
    Morreal CE; Dao TL; Nemoto T; Lonergan PA
    J Natl Cancer Inst; 1979 Nov; 63(5):1171-4. PubMed ID: 291747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma.
    Rizkallah TH; Tovell HM; Kelly WG
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1045-56. PubMed ID: 1133154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androstenedione metabolism in patients with endometrial cancer.
    Calanog A; Sall S; Gordon GG; Southren AL
    Am J Obstet Gynecol; 1977 Nov; 129(5):553-6. PubMed ID: 910844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer.
    Levin J; Markham MJ; Greenwald ES; O'Connor JF; Zumoff B; Fukushima DK
    Anticancer Res; 1982; 2(6):377-80. PubMed ID: 7168557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of estrone sulfate in human endometrium.
    Carlström K; von Uexküll AK; Einhorn N; Fredricsson B; Lunell NO; Sundelin P
    Acta Obstet Gynecol Scand; 1983; 62(5):519-24. PubMed ID: 6666565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between urine and plasma estrogen ratios.
    Longcope C; Pratt JH
    Cancer Res; 1978 Nov; 38(11 Pt 2):4025-8. PubMed ID: 698950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
    Reed MJ; Beranek PA; Ghilchik MW; James VH
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1395-400. PubMed ID: 3830220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and measurement of urinary estrone, estradiol-17 beta, estriol, pregnanediol and androsterone during the menstrual cycle of the orangutan.
    Collins DC; Graham CE; Preedy JR
    Endocrinology; 1975 Jan; 96(1):93-101. PubMed ID: 162882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women.
    Falk RT; Gail MH; Fears TR; Rossi SC; Stanczyk F; Adlercreutz H; Kiura P; Wahala K; Donaldson JL; Vaught JB; Fillmore CM; Hoover RN; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):567-77. PubMed ID: 10385149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamopituitary hyperactivity and endometrial carcinoma. Qualitative and quantitative disturbances in hormone production.
    Dilman VM; Berstein LM; Bobrov YF; Bohman YV; Kovaleva IG; Krylova NV
    Am J Obstet Gynecol; 1968 Nov; 102(6):880-9. PubMed ID: 5686906
    [No Abstract]   [Full Text] [Related]  

  • 14. Gas-liquid chromatographic quantitation of urinary estrogens in nonpregnant women, postmenopausal women, and men.
    Kaplan HG; Hreshchyshyn MM
    Am J Obstet Gynecol; 1971 Oct; 111(3):386-90. PubMed ID: 5095058
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Oestrogens as a cause of endometrial carcinoma.
    Br Med J; 1976 Apr; 1(6013):791-2. PubMed ID: 1260334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen profiles in young women: effect of maternal history of breast cancer.
    Morgan RW; Vakil DV; Brown JB; Elinson L
    J Natl Cancer Inst; 1978 May; 60(5):965-7. PubMed ID: 642038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian production of estrogens in postmenopausal women.
    Grönroos M; Klemi P; Salmi T; Rauramo L; Punnonen R
    Int J Gynaecol Obstet; 1980; 18(2):93-8. PubMed ID: 6108260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and endometrial carcinoma.
    Knab DR
    Obstet Gynecol Surv; 1977 May; 32(5):267-81. PubMed ID: 323764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE.
    MARMORSTON J; CROWLEY LG; MYERS SM; STERN E; HOPKINS CE
    Am J Obstet Gynecol; 1965 Jun; 92():460-7. PubMed ID: 14301686
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.
    Wright K; Collins DC; Preedy JR
    Steroids; 1979 Oct; 34(4):445-57. PubMed ID: 229588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.